Kyowa Hakko Bio Co. Ltd. engages in the manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use. The company was founded on October 1, 2008 and is headquartered in Tokyo, Japan.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

Zhejiang Hengkang Pharmaceutical Co., Ltd., established on 2004-10-27, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).(The branch office is located in:Chengen Road, Pubagang Town, Sanmen County, Zhejiang Province11No)

Eili Greenland Technology Co., Ltd., established on 2015-03-11, Business scope includes technology development;agricultural science research.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Erdos City Yili Resources Group Co. Ltd. is a Chinese private company located in Erdos providing investment services.

Hebei Lvyin Biochemical Technology Co., Ltd., established on 2005-09-05, Business scope includes chemical products(Except for dangerous chemicals and those requiring special approval),electronic product,software development,technology transfer,Wholesale and retail;compound fertilizer,organic fertilizer,microbial fertilizer,trace element fertilizer,urea,potash fertilizer,Production of agricultural machinery and equipment(branch only)and sales;Cultivation and sales of mushrooms;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shandong Shengwei Tourism Development Co., Ltd., established on 2009-05-08, Business scope includes operating domestic tourism business;Tourist information consultation service;Catering Services;Conference Services;stay;Amusement park management;bath service;indoor entertainment;haircut,beauty service;retail:Pre-packaged food,bulk food;retail cigarettes;real estate development,Sales;property management;real estate investment;Realtor;Real estate intermediary service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangxi Wo Ruide Biotechnology Co., Ltd., established on 2015-09-09, Business scope includes research on biological products,Development and technology transfer of biological products,Technical Services;Agricultural Technology Development,transfer;Agricultural and sideline product processing technology development,Research,transfer;For smart greenhouses and facilities,investment in agriculture;Production and sales:compound fertilizer,Organic and inorganic compound fertilizer,blended fertilizer,Organic Fertilizer,water soluble fertilizer,flush fertilization,Foliar fertilizer,liquid fertilizer,Microbial Fertilizer,Plant Growth Regulator,organic nutrient soil(Projects involving licenses operate with licenses,The specific project is subject to the approval of the approval authority);Sales:pesticide(Removal of hazardous chemicals),steel,No more subpackaged seeds,farm implement,Agricultural equipment,Chemical raw materials and products(Removal of hazardous chemicals);Installation of intelligent greenhouse equipment,Installation of agricultural irrigation equipment(Except for special equipment),Import and export business of self-management and general business items and technology;The import and export business of commodities and technologies for licensed business projects must obtain special approval from the state before operating(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Elion Resources Group Ltd. provides ecological industry and desert control services. It operates through the following business segments: Eco, Clean energy, and Finance. The Eco segment includes ecological environment restoration and construction of eco-towns. The Clean energy segment focuses on green energy, environmental protection, and air pollution control. The Finance segment includes a green finance platform that provides ecological environment protection and medical health services. The company was founded in 1988 and is headquartered in Beijing, China.

Cargill is an international producer and marketer of food, agricultural, financial, and industrial products, and services. Founded in 1865, Cargill privately held company employs 155,000 people in 70 countries. The company helps customers succeed through collaboration and innovation, and is committed to sharing our global knowledge and experience to help meet economic, environmental, and social challenges. Customers turn to Cargill for company scientific expertise when they need to improve an existing product, improve process efficiencies, or find a solution to help them launch a first-to-market innovation. The company's goal is to use Cargill's research and development capabilities to create distinct value through new, improved products, innovative cost-cutting methods, or both. The company's global team includes more than 1,300 research, development, applications, technical services, and intellectual property specialists working in more than 200 locations. Together, they provide a spectrum of services encompassing technical service, applications, development, research, intellectual asset management, and scientific and regulatory affairs.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Pm-International AG is a Luxembourgish private company located in Schengen with a presence in Switzerland, Germany, Norway and Sweden. The firm manufactures food supplements and cosmetics. It was founded in 1994 by Rolf Sorg, he is the current CEO of the company.

Cargill GmbH, a subsidiary of Cargill Holding (Germany) GmbH, is a company headquartered in Salzgitter, Germany, that produces and markets grain and oilseeds. It was founded in 1992. Hermann Steep is the CEO, in this role since 1998.\nThe company says this about itself: The Salzgitter location was one of our first production facilities in Germany. The two business units (oil mill and malthouse) went into production in 1993. We employ 115 qualified and dedicated skilled staff at the location in our oil mill, malthouse and laboratory, as well as in purchasing/sales departments, logistics and accounting. Products: Rapeseed oil – Hearty, healthy, and for everyday use, Rapeseed meal – A valuable source of protein in animal feed, Brewing malt – For the freshly tapped.

Domantis Ltd. develops antibody molecules. Domantis Ltd. offers dual targeting human domain antibodies, which are used against cytokine targets for inflammatory diseases, tumour antigens present on the same tumour cells, and tumour growth/angiogenic factors for solid tumours; human domain antibodies with tailored serum half-life that are customized to achieve the desired therapeutic effect; human domain antibodies for diverse therapeutic targets, which are suited to inhibit receptor targets; and injectable and non-injectable human domain antibodies that treat diseases of the lung, as well as disorders of the gastro-intestinal tract.

Yangzhou Rixing Biotechnology Co., Ltd., established on 2004-06-18, The business scope includes the production of glucosamine hydrochloride,Chitin,Chondroitin Sulfate,Oligochitosan,Shrimp paste,1-Aminoanthraquinone,Anthraquinone,Agmatine Sulfate,Astaxanthin,pyrazolone,higenamine hydrochloride,N-Acetyl-D-Glucosamine,Glucosamine Sulfate Potassium Salt,Glucosamine Sulfate Sodium Salt(The above does not contain raw materials,food additives,Hazardous chemicals and other items requiring permission);Production of food additive chitosan;Production,Operating chemical products that do not require an administrative license,Agricultural and sideline products;Sell ​​the company's own products;Shrimp and crab farming;biotechnology development;Health food production:Banglisheng brand glucosamine calcium vitaminDpiece.Carbazole Wholesale(Do not store).Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(The scope of business involves licensed operations,Operating with a license);pharmaceutical production;Drug Wholesale